This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
According to Newsweek, 13 of the top 20 hospitals for cardiac surgery in the entire world are located in the United States. The list includes 150 hospitals in total.
Cleerly and Clear Heart and Lung Imaging partnered to drive a cardiac-capable mobile CT scanner across Arizona, Louisiana, Georgia and Florida. Their goals were to evaluate patients in underserved parts of the United States and collect data for an ongoing clinical trial.
The overall mortality rate for U.S. patients with cardiovascular disease has improved significantly in recent years. At the same time, however, care gaps remain that must be addressed.
Research has shown that mistreatment at the hands of patients and other visitors is one of the leading drivers of burnout in the U.S. healthcare system. The new Cardio Safe initiative was built to combat that issue and protect the well-being of cardiologists and other cardiovascular health professionals.
The American Heart Association, American College of Cardiology and other U.S. medical societies have collaborated on new recommendations that cover everything from preoperative patient evaluations to postoperative care.
Readmission rates are getting lower over time among patients treated at nonprofit hospitals. At for-profit facilities, meanwhile, readmission rates have stayed relatively unchanged.
The Heart Failure Society of America has released a new comprehensive look at HF clinics in the United States. The report includes more than 300 programs that serve approximately 626,000 patients.
AI-based tools are here to stay, but one expert does not see them replacing cardiologists anytime soon. Look at recent trends in radiology, he says, to get a better idea of what cardiology's future may look like.
When heart patients are diagnosed with severe AS, how quickly do they need to undergo TAVR? That was the focus of a new analysis published in Open Heart.
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](/sites/default/files/styles/240x220/public/2024-09/istock-1209664264.jpg.webp?itok=OEoT1RAi)
